ROLE OF THE HYSTONE DEACETYLASE INHIBITOR GIVINOSTAT (ITF2357) IN TREATMENT OF CRLF2 REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA

被引:0
作者
Savino, A. M. [1 ]
Palmi, C. [1 ]
Fazio, G. [1 ]
Bardini, M. [1 ]
Rizzo, F. [1 ]
Cazzaniga, V. [1 ]
Bugarin, C. [1 ]
Fossati, G. [2 ]
Biondi, A. [1 ]
Cazzaniga, G. [1 ]
机构
[1] Univ Milano Bicocca, Tettamanti Res Ctr, Pediatr Dept, San Gerardo Hosp, Monza, Italy
[2] Italfarmaco SPA Cinisello Balsamo, Cinisello Balsamo, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P112
引用
收藏
页码:5 / 6
页数:2
相关论文
共 50 条
[41]   Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients [J].
Page, Elyse C. ;
Heatley, Susan L. ;
Yeung, David T. ;
Thomas, Paul Q. ;
White, Deborah L. .
CANCER LETTERS, 2018, 432 :69-74
[42]   Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia [J].
Charles G Mullighan ;
J Racquel Collins-Underwood ;
Letha A A Phillips ;
Michael G Loudin ;
Wei Liu ;
Jinghui Zhang ;
Jing Ma ;
Elaine Coustan-Smith ;
Richard C Harvey ;
Cheryl L Willman ;
Fady M Mikhail ;
Julia Meyer ;
Andrew J Carroll ;
Richard T Williams ;
Jinjun Cheng ;
Nyla A Heerema ;
Giuseppe Basso ;
Andrea Pession ;
Ching-Hon Pui ;
Susana C Raimondi ;
Stephen P Hunger ;
James R Downing ;
William L Carroll ;
Karen R Rabin .
Nature Genetics, 2009, 41 :1243-1246
[43]   Comprehensive detection of CRLF2 alterations in acute lymphoblastic leukemia: a rapid and accurate novel approach [J].
Gil, Jose Vicente ;
Miralles, Alberto ;
de las Heras, Sandra ;
Such, Esperanza ;
Avetisyan, Gayane ;
Diaz-Gonzalez, Alvaro ;
Santiago, Marta ;
Fuentes, Carolina ;
Fernandez, Jose Maria ;
Lloret, Pilar ;
Navarro, Irene ;
Montesinos, Pau ;
Llop, Marta ;
Barragan, Eva .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
[44]   Rearrangement of CRLF2 in B-Progenitor and Down Syndrome Associated Acute Lymphoblastic Leukemia [J].
Mullighan, Charles G. ;
Collins-Underwood, J. Racquel ;
Phillips, Letha A. ;
Loudin, Michael G. ;
Liu, Wei ;
Zhang, Jinghui ;
Ma, Jing ;
Coustan-Smith, Elaine ;
Harvey, Richard C. ;
Willman, Cheryl L. ;
Cheng, Jinjun ;
Mikhail, Fady M. ;
Meyer, Julia ;
Williams, Richard T. ;
Carroll, Andrew J. ;
Heerema, Nyla A. ;
Basso, Giuseppe ;
Pession, Andrea ;
Pui, Ching-Hon ;
Raimondi, Susana C. ;
Hunger, Stephen P. ;
Downing, James R. ;
Carroll, William L. ;
Rabin, Karen R. .
BLOOD, 2009, 114 (22) :80-80
[45]   CRLF2 expression associated with poor outcome in Philadelphia-negative acute lymphoblastic leukemia [J].
El-Afifi, Amal M. ;
Nabih, Nermeen A. ;
El Komy, Abdelallah A. ;
Elnahass, Yasser H. ;
Mohamed, Haydi S. .
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2025, 18 (02) :129-135
[46]   Molecular mechanisms of TSLP as a therapy for CRLF2 B-Cell acute lymphoblastic leukemia [J].
Alkashgari, Hossam ;
Stoian, Cornelia ;
Ruiz-Jimenez, Caleb ;
Coats, Jacqueline ;
Casiano, Carlos A. ;
Dovat, Sinisa ;
Payne, Kimberly J. .
CANCER RESEARCH, 2022, 82 (12)
[47]   Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia [J].
Rasekh, Eman O. ;
Atef, Asmaa M. ;
Khalil, Mohamed ;
Ebeid, Emad ;
Madney, Youssef ;
Hamdy, Nayera .
CLINICAL LABORATORY, 2021, 67 (01) :109-121
[48]   Biologic for the treatment of CRLF2 B-cell acute lymphoblastic leukemia to reduce pediatric cancer health disparities [J].
Stoian, Cornelia ;
Coats, Jacqueline S. ;
Vidales, Veriah ;
Personius, Juliette ;
Chirshev, Evgeny ;
Alkashgari, Hossam ;
Baez, Ineavely ;
Liu, Lawrence ;
Choi, Hannah ;
Dovat, Sinisa ;
Payne, Kimberly .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) :145-146
[49]   An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts [J].
M Pinazza ;
C Borga ;
V Agnusdei ;
S Minuzzo ;
G Fossati ;
M Paganin ;
B Michielotto ;
A De Paoli ;
G Basso ;
A Amadori ;
G te Kronnie ;
S Indraccolo .
Cell Death & Disease, 2016, 7 :e2047-e2047
[50]   Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations [J].
T D Buitenkamp ;
R Pieters ;
N E Gallimore ;
A van der Veer ;
J P P Meijerink ;
H B Beverloo ;
M Zimmermann ;
V de Haas ;
S M Richards ;
A J Vora ;
C D Mitchell ;
L J Russell ;
C Schwab ;
C J Harrison ;
A V Moorman ;
M M van den Heuvel-Eibrink ;
M L den Boer ;
C M Zwaan .
Leukemia, 2012, 26 :2204-2211